Mouse CD20 expression and function

International Immunology

Volumn 16, Issue 1, 2004, Pages 119-129

  Uchida, Junji ^a   Lee, Youngkyun ^a   Hasegawa, Minoru ^a   Liang, Yianghua ^a   Bradney, Alice ^a   Oliver, Julie A ^a   Bowen, Kristina ^a   Steeber, Douglas A ^a   Haas, Karen M ^a   Poe, Jonathan C ^a   Tedder, Thomas F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

B lymphocyte; Immunotherapy; Knockout mouse; mAb; Signal transduction

Indexed keywords

BIOLOGICAL MARKER; CALCIUM; CD19 ANTIGEN; CD20 ANTIBODY; CD20 ANTIGEN; COMPLEMENTARY DNA; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANTIBODY AFFINITY; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; B LYMPHOCYTE; BIOCHEMISTRY; BONE MARROW CELL; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL MATURATION; CELL MEMBRANE; CONTROLLED STUDY; DENSITY; DNA TRANSFECTION; FREQUENCY ANALYSIS; IMMUNOTHERAPY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE RECIRCULATION; LYMPHOCYTE SUBPOPULATION; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPLEEN CELL; T LYMPHOCYTE; TISSUE DISTRIBUTION; WILD TYPE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD20; B-LYMPHOCYTES; CALCIUM; CELL DIFFERENTIATION; CELL LINE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; HYBRIDOMAS; IMMUNOGLOBULIN M; LYMPHOCYTE ACTIVATION; MICE; SIGNAL TRANSDUCTION;

EID: 0346728609     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxh009     Document Type: Article

References (59)

1. Tedder, T. F. and Engel, P. 1994. CD20: a regulator of cell-cycle progression of B lymphocytes. Immunol. Today 15:450.
2. Stashenko, P., Nadler, L. M., Hardy, R. and Schlossman, S. F. 1980. Characterization of a human B lymphocyte-specific antigen. J. Immunol. 125:1678.
3. Stashenko, P., Nadler, L. M., Hardy, R. and Schlossman, S. F. 1981. Expression of cell surface markers after human B lymphocyte activation. Proc. Natl Acad. Sci. USA 78:3848.
4. Loken, M. R., Shah, V. O., Dattilio, K. L. and Civin, C. I. 1987. Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development. Blood 70:1316.
5. Tedder, T. F., Klejman, G., Disteche, C. M., Adler, D. A., Schlossman, S. F. and Saito, H. 1988. Cloning of complementary DNA encoding a new mouse B lymphocyte differentiation antigen, homologous to the human B1 (CD20) antigen and localization of the gene to chromosome 19. J. Immunol. 141:4388.
6. Tedder, T. F., Streuli, M., Schlossman, S. F. and Saito, H. 1988. Isolation and structure of a cDNA encoding the B1 (CD20) cell-surface antigen of human B lymphocytes. Proc. Natl Acad. Sci. USA 85:208.
7. Einfeld, D. A., Brown, J. P., Valentine, M. A., Clark, E. A. and Ledbetter, J. A. 1988. Molecular cloning of the human B-cell CD20 receptor predicts a hydrophobic protein with multiple transmembrane domains. EMBO J. 7:711.
8. Stamenkovic, I. and Seed, B. 1988. Analysis of two cDNA clones encoding the B lymphocyte antigen CD20 (B1, Bp35), a type III integral membrane protein. J. Exp. Med. 167:1975.
9. Tedder, T. F., McIntyre, G. and Schlossman, S. F. 1988. Heterogeneity in the B1 (CD20) cell surface molecule expressed by human B lymphocytes. Mol. Immunol. 25:1321.
10. Tedder, T. F. and Schlossman, S. F. 1988. Phosphorylation of the B1 (CD20) cell surface molecule expressed by normal and malignant human B lymphocytes. J. Biol. Chem. 263:10009.
11. Valentine, M. A., Cotner, T., Gaur, L., Torres, R. and Clark, E. A. 1987. Expression of the human B cell surface protein CD20: alteration by phorbol 12-myristate 12-acetate. Proc. Natl Acad. Sci. USA 84:8085.
12. Tedder, T. F., Boyd, A. W., Freedman, A. S., Nadler, L. M. and Schlossman, S. F. 1985. The B cell surface molecule B1 is functionally linked with B cell activation and differentiation. J. Immunol. 135:973.
13. ++ conductance found constitutively in B lymphocytes. J. Cell Biol. 121:1121.
14. Smeland, E., Godal, T., Rudd, E., Beiske, K., Funderud, S., Clark, E. A., Pfeifer-Ohlsson, S. and Ohlsson, R. 1985. The specific induction of myc protooncogene expression in normal human B cells is not a sufficient event for acquisition of competence to proliferate. Proc. Natl Acad. Sci. USA 82:6255.
15. Golay, J., Cusmano, G. and Introna, M. 1992. Independent regulation of c-myc, B-myb, and c-myb gene expression by inducers and inhibitors of proliferation in human B lymphocytes. J. Immunol. 149:300.
16. Deans, J. P., Schieven, G. L., Shu, G. L., Valentine, M. A., Gilliland, L. A., Aruffo, A., Clark, E. A. and Ledbetter, J. A. 1993. Association of tyrosine and serine kinases with the B cell surface antigen CD20. Induction via CD20 of tyrosine phosphorylation and activation of phospholipase C-γ1 and PLC phospholipase C-γy2. J. Immunol. 151:4494.
17. White, M. W., McConnell, F., Shu, G. L., Morris, D. R. and Clark, E. A. 1991. Activation of dense human tonsilar B cells: induction of c-myc gene expression via two distinct signal transduction pathways. J. Immunol. 146:846.
18. Clark, E. A. and Shu, G. 1987. Activation of human B cell proliferation through surface Bp35 (CD20) polypeptides or immunoglobulin receptors. J. Immunol. 138:720.
19. Kansas, G. S. and Tedder, T. F. 1991. Transmembrane signals generated through MHC class II, CD19, CD20, CD39, and CD40 antigens induce LFA-1-dependent and independent adhesion in human B cells through a tyrosine kinase-dependent pathway. J. Immunol. 147:4094.
20. Tedder, T. F., Forsgren, A., Boyd, A. W., Nadler, L. M. and Schlossman, S. F. 1986. Antibodies reactive with the B1 molecule inhibit cell cycle progression but not activation of human B lymphocytes. Eur. J. Immunol. 16:881.
21. 1 phase. J. Immunol. 135:3795.
22. Golay, J. T. and Crawford, D. H. 1987. Pathways of human B-lymphocyte activation blocked by B-cell specific monoclonal antibodies. Immunology 62:279.
23. Holder, M., Grafton, G., MacDonald, I., Finney, M. and Gordon, J. 1995. Engagement of CD20 suppresses apoptosis in germinal center B cells. Eur. J. Immunol. 25:3160.
24. Shan, D., Ledbetter, J. A. and Press, O. W. 1998. Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies. Blood 91:1644.
25. 1 phase in Balb/c 3T3 cells. J. Biol. Chem. 270:13099.
26. i protein. J. Biol. Chem. 272:14733.
27. Kanzaki, M., Nie, L., Shibata, H. and Kojima, I. 1997. Activation of a calcium-permeable cation channel CD20 expressed in Balb/c 3T3 cells by insulin-like growth factor-I. J. Biol. Chem. 272:4964.
28. O'Keefe, T. L., Williams, G. T., Davies, S. L. and Neuberger, M. S. 1998. Mice carrying a CD20 gene disruption. Immunogenetics 48:125.
29. Anderson, K. C., Bates, M. P., Slaughenhoupt, B., Pinkus, G., Schlossman, S. F. and Nadler, L. M. 1984. Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation. Blood 63:1424.
30. 131I]anti-B1 (anti-CD20) antibody. N. Engl. J. Med. 329:459.
31. Weiner, L. M. 1999. Monoclonal antibody therapy of cancer. Semin. Oncol. 26:43.
32. Onrust, S. V., Lamb, H. M. and Balfour, J. A. 1999. Rituximab. Drugs 58:79.
33. McLaughlin, P., White, C. A., Grillo-Lopez, A. J. and Maloney, D. G. 1998. Clinical status and optimal use of rituximab for B-cell lymphomas. Oncology 12:1763.
34. Maloney, D. G., Grillo-L'opez, A. J., White, C. A., Bodkin, D., Schilder, R. J., Neidhart, J. A., Janakiraman, N., Foon, K. A., Liles, T. M., Dallaire, B. K., Wey, K., Royston, I., Davis, T. and Levy, R. 1997. IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood 90:2188.
35. Reff, M. E., Carner, K., Chambers, K. S., Chinn, P. C., Leonard, J. E., Raab, R., Newman, R. A. and Hanna, N. 1994. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood 83:435.
36. Kaminski, M. S., Zasadny, K. R., Francis, I. R., Fenner, M. C., Ross, C. W., Milk, A. W., Estes, J., Tuck, M., Regan, D., Fisher, S., Glenn, S. D. and Wahl, R. L. 1996. Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma. J. Clin. Oncol. 14:1974.
37. Liu, S. Y., Eary, J. F., Petersdorf, S. H., Martin, P. J., Maloney, D. G., Appelbaum, F. R., Matthews, D. C., Bush, S. A., Durack, L. D., Fisher, D. R., Gooley, T. A., Bernstein, I. D. and Press, O. W. 1998. Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue. J. Clin. Oncol. 16:3270.
38. Tedder, T. F., Klejman, G., Schlossman, S. F. and Saito, H. 1989. Structure of the gene encoding the human B lymphocyte differentiation antigen CD20 (B1). J. Immunol. 142:2560.
39. 2-microglobulin locus in mouse embryonic stem cells by homologous recombination. Proc. Natl Acad. Sci. USA 86:8932.
40. Zhou, L.-J., Smith, H. M., Waldschmidt, T. J., Schwarting, R., Daley, J. and Tedder, T. F. 1994. Tissue-specific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B lymphocyte development. Mol. Cell. Biol. 14:3884.
41. Kearney, J. F., Radbruch, A., Liesegang, B. and Rajewsky, K. 1979. A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. J. Immunol. 123:1548.
42. Fujimoto, M., Bradney, A. P., Poe, J. C., Steeber, D. A. and Tedder, T. F. 1999. Modulation of B lymphocyte antigen receptor signal transduction by a CD19/CD22 regulatory loop. Immunity 11:191.
43. Bradbury, L. E., Kansas, G. S., Levy, S., Evans, R. L. and Tedder, T. F. 1992. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J. Immunol. 149:2841.
44. Fujimoto, M., Poe, J. C., Jansen, P. J., Sato, S. and Tedder, T. F. 1999. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation. J. Immunol. 162:7088.
45. Leveille, C., Al-Daccak, R. and Mourad, W. 1999. CD20 is physically and functionally coupled to MHC class II and CD40 on human B cell lines. Eur. J. Immunol. 29:65.
46. Engel, P., Zhou, L.-J., Ord, D. C., Sato, S., Koller, B. and Tedder, T. F. 1995. Abnormal B lymphocyte development, activation and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 3:39.
47. Jacob, R., Kassir, R. and Kelsoe, G. 1991. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations. J. Exp. Med. 173:1165.
48. Takahashi, Y., Dutta, P. R., Cerasoli, D. M. and Kelsoe, G. 1998. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. V. Affinity maturation develops in two stages of clonal selection. J. Exp. Med. 187:885.
49. Loder, F., Mutschler, B., Ray, R. J., Paige, C. J., Sideras, P., Torres, R., Lamers, M. C. and Carsetti, R. 1999. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J. Exp. Med. 190:75.
50. Genot, E. M., Meier, K. E., Licciardi, K. A., Ahn, N. G., Uittenbogaart, C. H., Wietzerbin, J., Clark, E. A. and Valentine, M. A. 1993. Phosphorylation of CD20 in cells from a hairy cell leukemia cell line. Evidence for involvement of calcium/calmodulin-dependent protein kinase II. J. Immunol. 151:71.
51. Carsetti, R., Köhler, G. and Lamers, M. C. 1995. Transitional B cells are the target of negative selection in the B cell compartment. J. Exp. Med. 181:2129.
52. Liang, Y. and Tedder, T. F. 2001. Identification of a CD20, FcERIβ and HTm4 related gene family. Sixteen new MS4A family members expressed in human and mouse. Genomics 72:119.
53. Liang, Y., Buckley, T. R., Tu, L., Langdon, S. D. and Tedder, T. F. 2001. Structural organization of the human MS4A gene cluster on chromosome 11q12: twelve members of the CD20, FcERIβ and HTm4 gene family. Immunogenetics 53:357.
54. Genot, E., Valentine, M. A., Degos, L., Sigaux, F. and Kolb, J. P. 1991. Hyperphosphorylation of CD20 in hairy cells. Alteration by low molecular weight B cell growth factor and IFN-alpha. J. Immunol. 146:870.
55. Valentine, M. A., Meier, K. E., Rossie, S. and Clark, E. A. 1989. Phosphorylation of the CD20 phosphoprotein in resting B lymphocytes: regulation by protein kinase C. J. Biol. Chem. 264:11282.
56. Valentine, M. A., Licciaradi, K. A., Clark, E. A., Krebs, E. G. and Meier, K. E. 1993. Insulin regulates serine/threonine phosphorylation in activated human B lymphocytes. J. Immunol. 150:96.
57. Oettgen, H. C., Bayard, P. J., Van Ewijk, W., Nadler, L. M. and Terhorst, C. P. 1983. Further biochemical studies of the human B-cell antigens B1 and B2. Hybridoma 2:17.
58. Deans, J. P., Kalt, L., Ledbetter, J. A., Schieven, G. L., Bolen, J. B. and Johnson, P. 1995. Association of 75/80-kDa phosphoproteins and the tyrosine kinases Lyn, Fyn, and Lck with the B cell molecule CD20. Evidence against involvement of the cytoplasmic regions of CD20. J. Biol. Chem. 270:22632.
59. Chu, P. G., Chen, Y.-Y., Molina, A., Arber, D. A. and Weiss, L. M. 2002. Recurrent B-cell neoplasms after Rituximab therapy: an immunophenotypic and genotypic study. Leuk. Lymph. 43:2335.